These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28739033)

  • 21. Transcatheter aortic valve implantation in patients with LV dysfunction: impact on mortality and predictors of LV function recovery.
    Elhmidi Y; Bleiziffer S; Deutsch MA; Krane M; Mazzitelli D; Lange R; Piazza N
    J Invasive Cardiol; 2014 Mar; 26(3):132-8. PubMed ID: 24610508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome prediction following transcatheter aortic valve implantation: Multiple risk scores comparison.
    Zbroński K; Huczek Z; Puchta D; Paczwa K; Kochman J; Wilimski R; Scisło P; Rymuza B; Filipiak KJ; Opolski G
    Cardiol J; 2016; 23(2):169-77. PubMed ID: 26711463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline NT-proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation.
    Allen CJ; Joseph J; Patterson T; Hammond-Haley M; McConkey HZR; Prendergast BD; Marber M; Redwood SR
    J Am Heart Assoc; 2020 Dec; 9(23):e017574. PubMed ID: 33241754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of Long-Term Mortality in Patients With Acute Heart Failure.
    Jin M; Wei S; Gao R; Wang K; Xu X; Yao W; Zhang H; Zhou Y; Xu D; Zhou F; Li X
    Int Heart J; 2017 May; 58(3):409-415. PubMed ID: 28496020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.
    Rheude T; Pellegrini C; Núñez J; Joner M; Trenkwalder T; Mayr NP; Holdenrieder S; Bodi V; Koenig W; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C; Husser O
    Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):907-915. PubMed ID: 30482731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does residual aortic regurgitation after transcatheter aortic valve implantation increase mortality in all patients? The importance of baseline natriuretic peptides.
    Borz B; Durand E; Godin M; Tron C; Canville A; Hauville C; Bauer F; Cribier A; Eltchaninoff H
    Int J Cardiol; 2014 May; 173(3):436-40. PubMed ID: 24679693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness and validation of the survival posT TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis.
    D'Ascenzo F; Capodanno D; Tarantini G; Nijhoff F; Ciuca C; Rossi ML; Brambilla N; Barbanti M; Napodano M; Stella P; Saia F; Ferrante G; Tamburino C; Gasparetto V; Agostoni P; Marzocchi A; Presbitero P; Bedogni F; Cerrato E; Omedè P; Conrotto F; Salizzoni S; Biondi Zoccai G; Marra S; Rinaldi M; Gaita F; D'Amico M; Moretti C
    Am J Cardiol; 2014 Dec; 114(12):1867-74. PubMed ID: 25438915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in Risk Stratification in Transcatheter Aortic Valve Implantation Using a Combination of the Tumor Marker CA125 and the Logistic EuroSCORE.
    Husser O; Núñez J; Burgdorf C; Holzamer A; Templin C; Kessler T; Bodi V; Sanchis J; Pellegrini C; Luchner A; Maier LS; Schmid C; Lüscher TF; Schunkert H; Kastrati A; Hilker M; Hengstenberg C
    Rev Esp Cardiol (Engl Ed); 2017 Mar; 70(3):186-193. PubMed ID: 27623490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Risk in Transcatheter Aortic Valve Implantation: Comparative Analysis of EuroSCORE II and Established Risk Stratification Tools.
    Silaschi M; Conradi L; Seiffert M; Schnabel R; Schön G; Blankenberg S; Reichenspurner H; Diemert P; Treede H
    Thorac Cardiovasc Surg; 2015 Sep; 63(6):472-8. PubMed ID: 25191764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of the "TAVI2-SCORe" versus surgical risk scores for prediction of one year mortality in 511 patients who underwent transcatheter aortic valve implantation.
    Debonnaire P; Fusini L; Wolterbeek R; Kamperidis V; van Rosendael P; van der Kley F; Katsanos S; Joyce E; Tamborini G; Muratori M; Gripari P; Bax JJ; Marsan NA; Pepi M; Delgado V
    Am J Cardiol; 2015 Jan; 115(2):234-42. PubMed ID: 25432413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of 30-day mortality after transcatheter aortic valve implantation: a comparison of logistic EuroSCORE, STS score, and EuroSCORE II.
    Johansson M; Nozohoor S; Zindovic I; Nilsson J; Kimblad PO; Sjögren J
    J Heart Valve Dis; 2014 Sep; 23(5):567-74. PubMed ID: 25799705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk.
    Schymik G; Heimeshoff M; Bramlage P; Herbinger T; Würth A; Pilz L; Schymik JS; Wondraschek R; Süselbeck T; Gerhardus J; Luik A; Gonska BD; Tzamalis P; Posival H; Schmitt C; Schröfel H
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):738-44. PubMed ID: 25641398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of body mass index in transcatheter aortic valve implantation: A "J"-shaped curve.
    González-Ferreiro R; Muñoz-García AJ; López-Otero D; Avanzas P; Pascual I; Alonso-Briales JH; Trillo-Nouche R; Pun F; Jiménez-Navarro MF; Hernández-García JM; Morís C; González Juanatey JR
    Int J Cardiol; 2017 Apr; 232():342-347. PubMed ID: 28089155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing characteristics and outcomes of patients undergoing surgical aortic valve replacement in the transcatheter aortic valve implantation era.
    Rozen G; Fefer P; Shinfeld A; Sternik L; Guetta V; Malachy A; Levin S; Feinberg M; Raanani E; Segev A
    J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):261-6. PubMed ID: 25004001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation.
    Osnabrugge RL; Speir AM; Head SJ; Fonner CE; Fonner E; Kappetein AP; Rich JB
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):400-8; discussion 408. PubMed ID: 24574449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: insights from spirometry and body plethysmography.
    Gotzmann M; Knoop H; Ewers A; Mügge A; Walther JW
    Am Heart J; 2015 Oct; 170(4):837-842.e1. PubMed ID: 26386809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin like growth factor binding protein 2 (IGFBP-2) for risk prediction in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI).
    Muessig JM; Lichtenauer M; Wernly B; Kelm M; Franz M; Bäz L; Schulze PC; Racher V; Zimmermann G; Figulla HR; Paar V; Hoppe UC; Rouet P; Lauten A; Jung C
    Int J Cardiol; 2019 Feb; 277():54-59. PubMed ID: 30309683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration.
    Homsak E; Ekart R
    Clin Chim Acta; 2018 Feb; 477():105-112. PubMed ID: 29221927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.